QUANTUM GENOMICS SAS-REGR (ALQGC.PA)

FR0011648971 - Common Stock

0.0721  0 (-1.77%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024
Revenue
YoY % growth
116.21K
-90.34%		604.98K
420.59%		10.06K
-98.34%		138.69M
1,378,528.23%
EBITDA
YoY % growth
-18.901M
-38.09%		N/A
35.13%		N/A
53.80%		70.813M
1,350.01%
EBIT
YoY % growth
-19.187M
-38.46%		-30.083M
-56.79%		-3.137M
89.57%		70.607M
2,350.60%
Operating Margin
-16,510.65%-4,972.59%-31,185.39%50.91%
EPS
YoY % growth
N/A
-200.63%		N/A
22.11%		N/A
81.08%		4.34
6,121.43%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth
-425.00%		-0.27%
Q2 2021
Q2Q % growth
21.72%		-0.20%
Q2 2020
Q2Q % growth		 -0.25 -0.320.0721.70%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 10.06K
-98.34%		%
Q4 2022
Q2Q % growth
-100.00%		%
Q2 2022
Q2Q % growth		 604.98K
495.22%		%
Q4 2021
Q2Q % growth		 14.57K
-98.79%		6.18M-6.165M-99.76%
Q2 2021
Q2Q % growth		 101.64K 6.18M-6.078M-98.36%
Q4 2020
Q2Q % growth		 1.203M 10.3M-9.097M-88.32%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%